Bioengineering strategies for regeneration of craniofacial bone: A review of emerging technologies

Oral Diseases

Volumn 16, Issue 8, 2010, Pages 709-716

  Ward, B ^a   Brown, S ^b   Krebsbach, P H ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bone; Craniofacial; Gene therapy; Regeneration; Stem cells; Tissue engineering

Indexed keywords

BIOMATERIAL;

BIOENGINEERING; BONE DEFECT; BONE REGENERATION; CARTILAGE CELL; CRANIOFACIAL MORPHOLOGY; GENE THERAPY; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; BIOENGINEERING; BIOMEDICAL TECHNOLOGY; BONE REGENERATION; FACIAL BONES; GENE THERAPY; HUMANS; SKULL; STEM CELLS; TISSUE ENGINEERING;

EID: 77958174034     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01682.x     Document Type: Review

References (95)

1. Abbah SA, Lu WW, Chan D et al (2006). In vitro evaluation of alginate encapsulated adipose-tissue stromal cells for use as injectable bone graft substitute. Biochem Biophys Res Commun 347: 185-191.
2. Ahn S, Kim S, Park K et al (2006). Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem Biophys Res Commun 340: 403-408.
3. Alden TD, Beres EJ, Laurent JS et al (2000). The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J Craniofac Surg 11: 24-30.
4. Alhadlaq A, Mao JJ (2003). Tissue-engineered neogenesis of human-shaped mandibular condyle from rat mesenchymal stem cells. J Dent Res 82: 951-956.
5. Alhadlaq A, Mao JJ (2005). Tissue-engineered osteochondral constructs in the shape of an articular condyle. J Bone Joint Surg Am 87: 936-944.
6. Alsberg E, Hill E, Mooney D (2001). Craniofacial tissue engineering. Crit Rev Oral Biol Med 12: 64-75.
7. Anusaksathien O, Jin Q, Zhao M, Somerman MJ, Giannobile WV (2004). Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum. J Periodontol 75: 429-440.
8. Arpornmaeklong P, Brown SE, Wang Z, Krebsbach PH (2009). Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev 18: 955-968.
9. Barberi T, Willis LM, Socci ND, Studer L (2005). Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2: e161.
10. Bessa PC, Casal M, Reis RL (2008). Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2: 81-96.
11. Betz OB, Betz VM, Abdulazim A et al (2010).The repair of critical size bone defects using expedited, autologous BMP-2 gene activated fat implants. Tissue Eng Part A 16: 1093-1101.
12. Bielby B, Boccaccini A, Polak J, Buttery L (2004). In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 10: 1518-1525.
13. Brown SE, Tong W, Krebsbach PH (2009). The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs 189: 256-260.
14. Cao T, Heng B, Ye C et al (2005). Osteogenic differentiation within intact human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days of in vitro culture, and formation of morphologically distinct nodule-like structures. Tissue Cell 37: 325-334.
15. Carstens MH, Chin M, Ng T, Tom WK (2005). Reconstruction of #7 facial cleft with distraction-assisted in situ osteogenesis (DISO): role of recombinant human bone morphogenetic protein-2 with Helistat-activated collagen implant. J Craniofac Surg 16: 1023-1032.
16. Chang SH, Hsu YM, Wang YJ, Tsao YP, Tung KY, Wang TY (2009). Fabrication of pre-determined shape of bone segment with collagen-hydroxyapatite scaffold and autogenous platelet-rich plasma. J Mater Sci Mater Med 20: 23-31.
17. Chesnutt BM, Yuan Y, Buddington K, Haggard WO, Bumgardner JD (2009). Composite chitosan/nano-hydroxyapatite scaffolds induce osteocalcin production by osteoblasts in vitro and support bone formation in vivo. Tissue Eng Part A 15: 2571-2579.
18. Cotrim AP, Mineshiba F, Sugito T, Samuni Y, Baum BJ (2006). Salivary gland gene therapy. Dent Clin North Am 50: 157-173, vii.
19. Couly GF, Coltey PM, Le Douarin NM (1993). The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development 117: 409-429.
20. Disa JJ, Cordeiro PG (2000). Mandible reconstruction with microvascular surgery. Semin Surg Oncol 19: 226-234.
21. Dunn CA, Jin Q, Taba M Jr, Franceschi RT, Bruce Rutherford R, Giannobile WV (2005). BMP gene delivery for alveolar bone engineering at dental implant defects. Mol Ther 11: 294-299.
22. Duplomb L, Dagouassat M, Jourdon P, Heymann D (2007). Concise review: Embryonic stem cells: a new tool to study osteoblast and osteoclast differentiation. Stem Cells 25: 544-552.
23. Edwards PC, Ruggiero S, Fantasia J et al (2005). Sonic hedgehog gene-enhanced tissue engineering for bone regeneration. Gene Ther 12: 75-86.
24. Emerick KS, Teknos TN (2007). State-of-the-art mandible reconstruction using revascularized free-tissue transfer. Expert Rev Anticancer Ther 7: 1781-1788.
25. Friedenstein AJ, Piatetzky S II, Petrakova KV (1966). Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16: 381-390.
26. Gafni Y, Pelled G, Zilberman Y et al (2004). Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 9: 587-595.
27. Gersbach CA, Coyer SR, Le Doux JM, Garcia AJ (2007). Biomaterial-mediated retroviral gene transfer using self-assembled monolayers. Biomaterials 28: 5121-5127.
28. Giesen EB, Ding M, Dalstra M, Van Eijden TM (2004). Changed morphology and mechanical properties of cancellous bone in the mandibular condyles of edentate people. J Dent Res 83: 255-259.
29. Goldstein RS, Pomp O, Brokhman I, Ziegler L (2010). Generation of neural crest cells and peripheral sensory neurons from human embryonic stem cells. Methods Mol Biol 584: 283-300.
30. Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, Simmons PJ (1999). Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 14: 47-56.
31. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97: 13625-13630.
32. Hao W, Hu YY, Wei YY et al (2008). Collagen I gel can facilitate homogenous bone formation of adipose-derived stem cells in PLGA-beta-TCP scaffold. Cells Tissues Organs 187: 89-102.
33. Hibi H, Yamada Y, Ueda M, Endo Y (2006). Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int J Oral Maxillofac Surg 35: 551-555.
34. Hollinger J, Winn S (1999). Tissue engineering of bone in the craniofacial complex. Ann NY Acad Sci 875: 379-385.
35. Hollister SJ (2005). Porous scaffold design for tissue engineering. Nat Mater 4: 518-524.
36. Hu WW, Ward BB, Wang Z, Krebsbach PH (2010). Bone regeneration in defects compromised by radiotherapy. J Dent Res 89: 77-81.
37. Hutmacher DW, Cool S (2007). Concepts of scaffold-based tissue engineering - the rationale to use solid free-form fabrication techniques. J Cell Mol Med 11: 654-669.
38. Hutmacher DW, Schantz JT, Lam CX, Tan KC, Lim TC (2007). State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 1: 245-260.
39. Jane JA Jr, Dunford BA, Kron A et al (2002). Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Mol Ther 6: 464-470.
40. Jang JH, Castano O, Kim HW (2009). Electrospun materials as potential platforms for bone tissue engineering. Adv Drug Deliv Rev 61: 1065-1083.
41. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM (2002). Tissue origins and interactions in the mammalian skull vault. Dev Biol 241: 106-116.
42. Jin Q, Anusaksathien O, Webb SA, Printz MA, Giannobile WV (2004). Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 9: 519-526.
43. Jones EA, Kinsey SE, English A et al (2002). Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46: 3349-3360.
44. Jones AC, Arns CH, Sheppard AP, Hutmacher DW, Milthorpe BK, Knackstedt MA (2007). Assessment of bone ingrowth into porous biomaterials using MICRO-CT. Biomaterials 28: 2491-2504.
45. Jones AC, Arns CH, Hutmacher DW, Milthorpe BK, Sheppard AP, Knackstedt MA (2009). The correlation of pore morphology, interconnectivity and physical properties of 3D ceramic scaffolds with bone ingrowth. Biomaterials 30: 1440-1451.
46. Karner E, Unger C, Sloan AJ, Richter-Ahrlund L, Sugars R, Wendel M (2007). Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem Cells Dev 16: 39-52.
47. Karp J, Ferreira L, Khademhosseini A, Kwon A, Yeh J, Langer R (2006). Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells 24: 835-843.
48. Kim HW, Song JH, Kim HE (2006). Bioactive glass nanofiber-collagen nanocomposite as a novel bone regeneration matrix. J Biomed Mater Res A 79: 698-705.
49. Kinnaird T, Stabile E, Burnett MS et al (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
50. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Robey PG (1997). Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63: 1059-1069.
51. Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG (1999). Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 10: 165-181.
52. Krebsbach PH, Gu K, Franceschi RT, Rutherford RB (2000). Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 11: 1201-1210.
53. Kretlow JD, Young S, Klouda L, Wong M, Mikos AG (2009). Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater Deerfield 21: 3368-3393.
54. Langer R, Vacanti JP (1993). Tissue engineering. Science 260: 920-926.
55. Lee JA, Parrett BM, Conejero JA et al (2003). Biological alchemy: engineering bone and fat from fat-derived stem cells. Ann Plast Surg 50: 610-617.
56. Lee CH, Marion NW, Hollister S, Mao JJ (2009). Tissue formation and vascularization in anatomically shaped human joint condyle ectopically in vivo. Tissue Eng Part A 15: 3923-3930.
57. Li WJ, Tuli R, Huang X, Laquerriere P, Tuan RS (2005). Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials 26: 5158-5166.
58. Lian Q, Lye E, Suan Yeo K et al (2007). Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells 25: 425-436.
59. Mao JJ, Giannobile WV, Helms JA et al (2006). Craniofacial tissue engineering by stem cells. J Dent Res 85: 966-979.
60. Meinel L, Karageorgiou V, Hofmann S et al (2004). Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A 71: 25-34.
61. Miura M, Gronthos S, Zhao M et al (2003). SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100: 5807-5812.
62. Morishita T, Honoki K, Ohgushi H, Kotobuki N, Matsushima A, Takakura Y (2006). Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 30: 115-118.
63. Murray PE, About I, Franquin JC, Remusat M, Smith AJ (2001). Restorative pulpal and repair responses. J Am Dent Assoc 132: 482-491.
64. Nakashima M, Iohara K, Zheng L (2006). Gene therapy for dentin regeneration with bone morphogenetic proteins. Curr Gene Ther 6: 551-560.
65. Nussenbaum B, Rutherford RB, Teknos TN, Dornfeld KJ, Krebsbach PH (2003). Ex vivo gene therapy for skeletal regeneration in cranial defects compromised by postoperative radiotherapy. Hum Gene Ther 14: 1107-1115.
66. Olivier EN, Rybicki AC, Bouhassira EE (2006). Differentiation of human embryonic stem cells in bipotent mesenchymal stem cells. Stem Cells 24: 1914-1922.
67. Palmer G, Pascher A, Gouze E et al (2002). Development of gene-based therapies for cartilage repair. Crit Rev Eukaryot Gene Expr 12: 259-273.
68. Peng H, Usas A, Gearhart B, Olshanski A, Shen HC, Huard J (2004a). Converse relationship between in vitro osteogenic differentiation and in vivo bone healing elicited by different populations of muscle-derived cells genetically engineered to express BMP4. J Bone Miner Res 19: 630-641.
69. Peng H, Usas A, Gearhart B, Young B, Olshanski A, Huard J (2004b). Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Mol Ther 9: 885-894.
70. Petrie C, Tholpady S, Ogle R, Botchwey E (2008). Proliferative capacity and osteogenic potential of novel dura mater stem cells on poly-lactic-co-glycolic acid. J Biomed Mater Res A 85: 61-71.
71. Potier E, Ferreira E, Andriamanalijaona R et al (2007). Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 40: 1078-1087.
72. Rabie AB, Dai J, Xu R (2007). Recombinant AAV-mediated VEGF gene therapy induces mandibular condylar growth. Gene Ther 14: 972-980.
73. Reddi AH (2005). BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev 16: 249-250.
74. Schek RM, Taboas JM, Segvich SJ, Hollister SJ, Krebsbach PH (2004). Engineered osteochondral grafts using biphasic composite solid free-form fabricated scaffolds. Tissue Eng 10: 1376-1385.
75. Schek RM, Taboas JM, Hollister SJ, Krebsbach PH (2005). Tissue engineering osteochondral implants for temporomandibular joint repair. Orthod Craniofac Res 8: 313-319.
76. Scheller EL, Krebsbach PH (2009). Gene therapy: design and prospects for craniofacial regeneration. J Dent Res 88: 585-596.
77. Scheller EL, Krebsbach PH, Kohn DH (2009). Tissue engineering: state of the art in oral rehabilitation. J Oral Rehabil 36: 368-389.
78. Seo BM, Miura M, Gronthos S et al (2004). Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364: 149-155.
79. Shayesteh YS, Khojasteh A, Soleimani M, Alikhasi M, Khoshzaban A, Ahmadbeigi N (2008). Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106: 203-209.
80. Shen HC, Peng H, Usas A et al (2004a). Ex vivo gene therapy-induced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone 34: 982-992.
81. Shen HC, Peng H, Usas A, Gearhart B, Fu FH, Huard J (2004b). Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J Gene Med 6: 984-991.
82. Shi S, Gronthos S, Chen S et al (2002). Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 20: 587-591.
83. Shi YY, Nacamuli RP, Salim A, Longaker MT (2005). The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plast Reconstr Surg 116: 1686-1696.
84. Solchaga LA, Gao J, Dennis JE et al (2002). Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng 8: 333-347.
85. Sotille V, Thomson A, McWhir J (2003). In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 5: 149-155.
86. Steiner C, Elixhauser A, Schnaier J (2002). The healthcare cost and utilization project: an overview. Eff Clin Pract 5: 143-151.
87. Thomson J, Itskovitz-Eldor J, Shapiro S et al (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
88. Tong W, Brown SE, Krebsbach PK (2007). Human embryonic stem cells undergo osteogenic differentiation in human bone marrow stromal cell microenvironments. J Stem Cells 2: 139-147.
89. Tu Q, Valverde P, Li S, Zhang J, Yang P, Chen J (2007). Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng 13: 2431-2440.
90. Ueno A, Kitase Y, Moriyama K, Inoue H (2001). MC3T3-E1-conditioned medium-induced mineralization by clonal rat dental pulp cells. Matrix Biol 20: 347-355.
91. Ulrich-Vinther M (2007). Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Acta Orthop Suppl 78: 1-64.
92. Voutetakis A, Zheng C, Metzger M et al (2008). Sorting of transgenic secretory proteins in rhesus macaque parotid glands after adenovirus-mediated gene transfer. Hum Gene Ther 19: 1401-1405.
93. Wang X, Hu X, Daley A, Rabotyagova O, Cebe P, Kaplan DL (2007). Nanolayer biomaterial coatings of silk fibroin for controlled release. J Control Release 121: 190-199.
94. Yoon E, Dhar S, Chun DE, Gharibjanian NA, Evans GR (2007). In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 13: 619-627.
95. Zuk PA, Zhu M, Mizuno H et al (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.